About The Report
Demand for non-vascular stents in the USA is expected to grow from USD 503.6 million in 2025 to USD 815.7 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.9%. This growth is driven by the increasing use of non-vascular stents in various medical applications, including gastrointestinal, biliary, and urological procedures. As the prevalence of conditions such as cancer, chronic obstructive pulmonary disease (COPD), and other diseases requiring non-vascular stenting continues to rise, the demand for these medical devices is expected to grow steadily. Non-vascular stents help to maintain open passageways in the body, improving the quality of life for patients with obstructed ducts or airways.
The market is further supported by technological advancements in stent materials, design, and coatings, which have improved stent performance and patient outcomes. The growing focus on minimally invasive procedures and the expanding healthcare infrastructure in the USA are also contributing factors to the rise in non-vascular stent adoption. With increasing aging populations and rising healthcare needs, the demand for non-vascular stents is expected to continue to expand over the next decade.
The breakpoint analysis for the non-vascular stents market in the USA shows consistent growth with key inflection points throughout the forecast period. Starting at USD 503.6 million in 2025, the market shows gradual growth, reaching USD 528.5 million in 2026 and USD 554.6 million in 2027. This early growth reflects steady adoption of non-vascular stents across various medical applications as their role in treatment becomes more widely recognized.
A significant breakpoint occurs between 2027 and 2028, where the growth rate accelerates. The market value moves from USD 582.0 million in 2028 to USD 610.7 million in 2029, marking an increase in demand driven by ongoing advancements in stent technology and the expansion of minimally invasive procedures. By 2030, the market reaches USD 640.9 million, with further growth to USD 672.6 million in 2031 and USD 705.8 million in 2032, showing a continued rise in demand.
In the later years of the forecast period, the market continues to grow steadily, reaching USD 740.7 million in 2033 and USD 777.3 million in 2034. The final breakpoint occurs between 2034 and 2035, with the market reaching USD 815.7 million, indicating a mature stage of market growth. The breakpoint analysis highlights the key acceleration phases where advancements in stent technology, broader healthcare access, and increasing patient need contribute to growth, followed by a steady progression towards market maturity.
| Metric | Value |
|---|---|
| Industry Sales Value (2025) | USD 503.6 million |
| Industry Forecast Value (2035) | USD 815.7 million |
| Industry Forecast CAGR (2025-2035) | 4.9% |
Demand for non vascular stents in the USA is increasing as the prevalence of chronic diseases affecting non vascular organs rises, particularly among aging populations. Conditions such as bile duct obstruction, ureteral strictures, gastrointestinal blockages, and esophageal narrowing often require minimally invasive intervention to restore normal function. Non vascular stents provide a critical solution by holding open ducts or passageways-for example in the biliary tract, ureters, or esophagus-preventing complications like organ failure, infection, or severe discomfort. Because these conditions are becoming more common, the need for reliable non vascular stents is growing.
At the same time, advances in stent technology and broader shifts in healthcare practices support increased adoption. Improvements in stent materials-including bioresorbable polymers and drug eluting coatings-have enhanced safety, reduced long term complications, and opened up applications in more delicate or complex anatomical sites. Minimally invasive procedures using non vascular stents are generally preferred over surgical alternatives because they reduce recovery time, lower risk, and minimize hospital stays. As hospitals and healthcare providers emphasize efficient, cost effective treatments that improve patient outcomes, demand for non vascular stents is expected to continue rising in the USA.
The non-vascular stents market in the USA is segmented by product type and material. Biliary stents lead the product type segment, holding 34% of the market share. In terms of material, metal stents dominate, accounting for 51.4% of the market. The growing prevalence of conditions such as biliary obstruction, esophageal cancer, and chronic obstructive pulmonary disease (COPD) is driving the adoption of non-vascular stents in the USA.
Biliary stents are the largest segment in the non-vascular stents market in the USA, representing 34% of the market share. Biliary stents are primarily used in the treatment of biliary obstruction, a condition commonly associated with liver diseases, pancreatic cancer, or gallstones. These stents are designed to keep the bile duct open, improving bile flow and alleviating symptoms like jaundice. The demand for biliary stents is driven by the rising incidence of liver and pancreatic diseases, as well as advances in minimally invasive surgical techniques. Other product types, such as esophageal stents, colonic stents, bronchial stents, and ureteral stents, also contribute to the market, but biliary stents remain the most widely used due to their effectiveness in treating common, life-threatening conditions.
Metal stents lead the material segment for non-vascular stents, holding 51.4% of the market share. Metal stents, typically made from stainless steel, nitinol, or cobalt-chromium alloys, are preferred for their durability, strength, and flexibility. These stents are commonly used in non-vascular applications due to their ability to maintain long-term patency, even in high-stress environments such as the bile duct or the esophagus. The material properties of metal stents, including their ability to conform to the shape of the surrounding tissue, make them suitable for a wide range of applications, particularly in biliary, esophageal, and bronchial stenting. Polymer stents and hybrid stents are also used, offering advantages like biodegradability and flexibility, but metal stents remain the dominant choice due to their superior mechanical properties and long-term reliability.
The demand for non-vascular stents in the USA is growing as healthcare providers increasingly use these devices in the treatment of various medical conditions that affect organs outside of the vascular system. Non-vascular stents are used in areas such as the urinary tract, biliary system, and gastrointestinal system to support the passage of fluids or prevent blockages. These stents help improve the quality of life for patients by ensuring proper organ function, reducing the risk of complications, and preventing the need for invasive surgeries. As the prevalence of conditions such as kidney stones, prostate disease, and bile duct obstructions rises, the market for non-vascular stents is expanding, supported by advancements in stent materials and technology.
What are the Drivers of Demand for Non-Vascular Stents in USA?
Several factors are driving the demand for non-vascular stents in the USA. First, the increasing prevalence of chronic conditions, such as kidney disease, prostate enlargement, and bile duct obstructions, is fueling the need for non-vascular stents to manage these health issues effectively. Second, advancements in medical device technology, including the development of stents made from more durable and biocompatible materials, are improving the performance and longevity of non-vascular stents. Third, the shift toward minimally invasive procedures in the healthcare industry has made stent implantation a preferred treatment option over traditional surgeries due to shorter recovery times and lower risks. Additionally, the growing aging population in the USA is contributing to higher rates of conditions that require non-vascular stents, further driving demand.
What are the Restraints on Demand for Non-Vascular Stents in USA?
Despite the growing demand for non-vascular stents, several factors may limit their adoption. One significant restraint is the potential for complications associated with stent placement, such as infection, migration, and obstruction, which may require additional procedures or surgeries. Another challenge is the cost of stent devices and procedures, which can be a barrier for some patients, especially those without adequate insurance coverage. Additionally, the need for skilled medical professionals to perform stent insertions and the potential for long-term monitoring may limit the widespread use of non-vascular stents in certain healthcare settings. Furthermore, some patients may experience discomfort or adverse reactions to the materials used in non-vascular stents, which could reduce their acceptance and use.
What are the Key Trends Influencing Demand for Non-Vascular Stents in USA?
Several key trends are influencing the demand for non-vascular stents in the USA. A major trend is the increasing adoption of minimally invasive techniques, which are encouraging healthcare providers to choose stent placement over traditional surgery for conditions such as kidney stones and bile duct obstructions. Another trend is the development of advanced stent materials, such as biodegradable and drug-eluting stents, which offer improved functionality and reduced risk of complications. Additionally, as the healthcare industry moves towards personalized and precision medicine, there is growing interest in tailoring stent designs to better suit individual patient needs. The expansion of outpatient care settings and day surgeries is also driving demand, as non-vascular stents allow for quicker recovery and fewer hospital stays. Lastly, the increasing awareness of treatment options among patients and the medical community is contributing to the greater adoption of non-vascular stents in the USA.
The Non-Vascular Stents market in the USA is projected to grow steadily, with the West USA leading the way at a projected CAGR of 5.7%. South USA follows closely with a growth rate of 5.1%, while the Northeast USA is expected to grow at 4.5%. The Midwest USA shows more moderate growth with a CAGR of 4%. Non-vascular stents, which are used to treat conditions outside the vascular system, such as in the biliary or ureteral systems, are gaining traction as the need for minimally invasive treatments and improved medical procedures rises. As healthcare providers continue to prioritize patient safety and effective treatment solutions, the demand for non-vascular stents is expected to increase.
| Region | CAGR (2025-2035) |
|---|---|
| West USA | 5.7% |
| South USA | 5.1% |
| Northeast USA | 4.5% |
| Midwest USA | 4% |
The West USA is projected to experience the highest growth in the Non-Vascular Stents market, with a projected CAGR of 5.7%. The region’s strong healthcare infrastructure, combined with a high adoption rate of innovative medical technologies, is a significant driver of this growth. States like California, Washington, and Oregon are leaders in medical technology adoption, and healthcare providers in the region are increasingly using non-vascular stents for a variety of treatments. The rise in minimally invasive procedures and advancements in stent design, which make them safer and more effective, is further fueling the market. Additionally, the growing demand for urological and gastrointestinal treatments in the West USA, along with an aging population, is contributing to the adoption of non-vascular stents. As the region continues to prioritize cutting-edge healthcare solutions, the market for non-vascular stents is expected to expand.
In South USA, the demand for non-vascular stents is projected to grow at a CAGR of 5.1%. The region’s large population, coupled with a rising incidence of urological and gastrointestinal diseases, is driving the demand for stent procedures. States like Texas, Florida, and Georgia are seeing increasing healthcare needs, and non-vascular stents are becoming a critical tool in treating a variety of non-vascular conditions. The South’s focus on improving healthcare accessibility and the adoption of advanced medical technologies is helping to fuel the growth of non-vascular stents. Additionally, the growing trend of minimally invasive surgeries, which reduce recovery time and improve patient outcomes, is further supporting the use of non-vascular stents in medical practice. As the region continues to adopt modern healthcare solutions, the demand for non-vascular stents is expected to grow steadily.
In Northeast USA, the Non-Vascular Stents market is projected to grow at a CAGR of 4.5%. The region’s well-established healthcare infrastructure, combined with its high healthcare spending, is supporting the adoption of non-vascular stents. The Northeast, particularly in cities like New York, Boston, and Philadelphia, is home to leading medical centers that specialize in advanced treatments for conditions requiring stent insertion. As patients seek safer, more effective treatments for gastrointestinal, urological, and other non-vascular conditions, the demand for non-vascular stents is increasing. The region’s strong focus on patient care and the adoption of minimally invasive medical technologies are contributing to the steady growth of the market. The increasing number of diagnostic procedures and interventions involving non-vascular stents further supports market expansion in the Northeast USA.
In Midwest USA, the Non-Vascular Stents market is expected to grow at a more moderate rate of 4.0%. The Midwest has a strong healthcare presence, with major medical centers and research institutions focused on advancing treatment options for non-vascular conditions. As the population ages and the incidence of urological and gastrointestinal diseases rises, the demand for non-vascular stents is increasing. States like Illinois, Michigan, and Ohio are seeing higher demand for these medical devices as part of treatment protocols for conditions such as biliary obstructions, ureteral blockages, and other non-vascular diseases. While the growth rate in the Midwest is slower compared to the West and South, the increasing focus on minimally invasive surgical options and patient care is driving the gradual adoption of non-vascular stents in the region. As healthcare providers seek more efficient, effective treatment solutions, the market for non-vascular stents is expected to continue expanding in the Midwest.
Demand for non vascular stents in the USA remains robust as clinicians increasingly rely on minimally invasive solutions to treat obstructions and strictures in non vascular conduits such as the gastrointestinal tract, urinary tract, biliary ducts, airways and other internal lumens. Rising incidence of chronic conditions-such as urological disorders, gastrointestinal cancers, biliary diseases, airway obstructions, and age related complications-fuels the need for stenting. Market data show that the global non vascular stents market was valued at around USD 1.6 billion in 2023 and is projected to grow steadily, with North America as a leading region. Use of self expandable, metallic or polymeric stents and growing adoption of drug coated or biodegradable stent variants support clinical demand owing to improved patient outcomes, reduced need for repeat surgeries, and shorter hospital stays.
On the supply side a few major medical device companies compete to meet this demand. According to your list, Boston Scientific Corporation leads with approximately 23 % share among the identified firms. Other significant suppliers include Becton, Dickinson and Company (BD), Medtronic, Cook Medical, and CONMED Corporation. These firms supply a range of non vascular stents: biliary, gastrointestinal, ureteral, airway and other specialty stents designed for different clinical indications. Competition among these suppliers centers on stent design (self expandable vs balloon expandable), material (metallic alloy vs polymer/bioresorbable), stent coating or drug elution for reduced restenosis or ingrowth, device biocompatibility, ease of placement and removal, regulatory approvals, and supply reliability. Suppliers that combine proven device performance, broad product portfolios across organ systems, regulatory compliance, and strong hospital/clinic distribution networks are best positioned to capture growth in the US non vascular stents market as demand expands.
| Items | Details |
|---|---|
| Quantitative Units | USD Million |
| Regions Covered | USA |
| Product Type | Biliary Stents, Esophageal Stents, Colonic Stents, Bronchial Stents, Ureteral Stents |
| Material | Metal Stents, Polymer Stents, Hybrid Stents |
| Application | Malignant Obstructions, Benign Obstructions, Palliative Care |
| Technology | Self Expanding Stents, Balloon Expandable Stents, Drug Eluting Stents, Biodegradable / Bioresorbable Stents, Anti Reflux Stents |
| End User | Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs) |
| Key Companies Profiled | Boston Scientific Corporation; Becton, Dickinson and Company (BD); Medtronic; Cook Medical; CONMED Corporation |
| Additional Attributes | Dollar sales by stent type and application indicate growing demand for self expanding and metal biliary/ureteral stents, especially for malignant and benign obstructions. Polymer and bioresorbable variants are gaining share as patient comfort and repeat procedure avoidance become priorities. Hospitals remain primary end users; rising incidence of GI, biliary, urological and airway obstructions among aging population supports steady growth. |
The demand for non-vascular stents in USA is estimated to be valued at USD 503.6 million in 2025.
The market size for the non-vascular stents in USA is projected to reach USD 815.7 million by 2035.
The demand for non-vascular stents in USA is expected to grow at a 4.9% CAGR between 2025 and 2035.
The key product types in non-vascular stents in USA are biliary stents, esophageal stents, colonic stents, bronchial stents and ureteral stents.
In terms of material, metal stents segment is expected to command 51.4% share in the non-vascular stents in USA in 2025.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Demand for Coronary Stents in USA Size and Share Forecast Outlook 2025 to 2035
The USA Meat Trays Market is segmented by Material (Polyethylene Terephthalate (PET), Polypropylene (PP), Polystyrene (PS), Polyvinyl Chloride (PVC), Polyethylene (PE), Paper & Molded Pulp, Polylactic Acid (PLA) and Other Bioplastics, Aluminum), Tray Type (Standard Overwrap Trays, Modified Atmosphere Packaging (MAP) Trays, Vacuum Skin Packaging (VSP) Trays), Manufacturing Process (Thermoformed Trays, Injection Molded Trays, Foam Extrusion Trays, Laminated or Coated Trays), Capacity (Small Portion Trays (≤250g), Medium Portion Trays (251g–500g), Large Portion Trays (501g–1 kg), Family/Bulk Trays (>1 kg)), Distribution Channel (Offline Retail, Online Retail, Institutional/B2B) and Region (North East, South West, West, South East, Midwest). Forecast for 2026 to 2036.
The USA Lawn Leaf Bags Market is segmented by Material (Plastic, Paper, Others), Closure (Drawstring Closure, Zipper Closure, Twist-tie Closure, Adhesive strip Closure, Elastic Closure), Capacity (5 – 10 Gallon, 10 -15 Gallon, 15- 30 Gallon, Above 30 Gallon), Distribution Channel (Manufacturers (Direct Sales), Bricks & Mortar Stores, Distributors, Online), End Use (Lawns & Garden, Commercial & Industrial Use, Domestic Use, Outdoor Activities (Camping, Hiking etc.)) and Region Forecast for 2026 to 2036.
The USA IBC Market is segmented by Material (Plastic IBC, Composite IBC, Steel IBC), Capacity (Up to 500 L, 501–1,000 L, 1,001–1,500 L, 1,501–2,000 L, Above 2,000 L), Supply Chain Model (New Sales, Leasing / Pooling Services, Reconditioning / Reseller), Design (Top-Fill IBCs, Bottom-Discharge IBCs, Stackable IBCs, Collapsible IBCs, Square / Rectangular IBCs, Cylindrical IBCs), Reusability (Single-use IBCs, Reusable IBCs, Reconditioned IBCs), End Use (Industrial Chemicals, Building & Construction, Petroleum & Lubricants, Pharmaceuticals & Healthcare, Paints, Inks & Coatings, Agriculture, Mining & Waste Management, Other Industrial Uses, Food & Beverage), and States. Forecast for 2026 to 2036.
USA Flexible Plastic Packaging Market Insights - Trends, Demand & Growth 2025-2035
Global Shale Gas Hydraulic Fracturing Market Outlook – Trends & Forecast 2026 to 2036
USA Golf Tourism Market Analysis – Growth, Applications & Outlook 2026 to 2036
USA Folding Carton Market Size and Share Forecast Outlook 2026 to 2036
USA Medical Coding Market Size and Share Forecast Outlook 2025 to 2035
USA Labels Market Size and Share Forecast Outlook 2025 to 2035
USA Plant-based Creamers Market Size and Share Forecast Outlook 2025 to 2035
USA Barrier Coated Paper Market Size and Share Forecast Outlook 2025 to 2035
USA Electronic Health Records (EHR) Market Size and Share Forecast Outlook 2025 to 2035
USA Animal Model Market Size and Share Forecast Outlook 2025 to 2035
USA and Canada Packer Bottle Market Size and Share Forecast Outlook 2025 to 2035
USA Stretch Hood Films Market Size and Share Forecast Outlook 2025 to 2035
USA and Canada Fence Screen Market Size and Share Forecast Outlook 2025 to 2035
USA Lubricant Contaminated HDPE Container Waste Market Size and Share Forecast Outlook 2025 to 2035
USA Commercial Walk-In Refrigeration Market Size and Share Forecast Outlook 2025 to 2035
USA & Canada Pre-painted Steel Roofing and Cladding Market Size and Share Forecast Outlook 2025 to 2035
Demand for Non-Vascular Stents in USA
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
